Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Active Moderate to Severe Rheumatoid Arthritis”

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT04413617
What this trial is testing

TO ASSESS THE EFFICACY AND SAFETY OF PF-06650833, PF-06651600, AND TOFACITINIB ALONE AND IN COMBINATION IN PARTICIPANTS WITH ACTIVE RHEUMATOID ARTHRITIS WITH AN INADEQUATE RESPONSE TO METHOTREXATE

Who this might be right for
Rheumatoid Arthritis
Pfizer 460
Testing effectiveness (Phase 2)Ended earlyNCT04888585
What this trial is testing

Study to Evaluate Adverse Events and Change in Disease Activity in Participants Between 18 to 75 Years of Age Treated With Subcutaneous (SC) Injections of ABBV-154 for Moderately to Severely Active Rheumatoid Arthritis (RA)

Who this might be right for
Rheumatoid Arthritis (RA)
AbbVie 473
Testing effectiveness (Phase 2)Study completedNCT04049448
What this trial is testing

Study Evaluating the Long-Term Safety and Efficacy of ABX464 in Patients With Moderate to Severe Rheumatoid Arthritis

Who this might be right for
Rheumatoid Arthritis
Abivax S.A. 40
Testing effectiveness (Phase 2)Study completedNCT04192617
What this trial is testing

Evaluate the Safety and Efficacy of SM03 in Patients With Rheumatoid Arthritis Receiving Methotrexate

Who this might be right for
Rheumatoid Arthritis
SinoMab BioScience Ltd 156
Not applicableStudy completedNCT01649817
What this trial is testing

A Retrospective Observational Study on Compliance in Patients With Rheumatoid Arthritis on Treatment With RoActemra/Actemra (Tocilizumab) in Clinical Practice (REMISSION II)

Who this might be right for
Rheumatoid Arthritis
Hoffmann-La Roche 183
Post-approval studies (Phase 4)Study completedNCT01089023
What this trial is testing

Tocilizumab as Monotherapy or in Combination With DMARDs in Patients With Moderate to Severe Active Rheumatoid Arthritis

Who this might be right for
Rheumatoid Arthritis
Hoffmann-La Roche 95
Not applicableStudy completedNCT03387423
What this trial is testing

Observational Study to Determine How Physicians Make Treatment Decisions in Patients Treated With Tofacitinib for Moderate to Severe Active Rheumatoid Arthritis

Who this might be right for
Arthritis, Rheumatoid
Pfizer 1,459
Testing effectiveness (Phase 2)Study completedNCT05279417
What this trial is testing

ATI-450 Plus Methotrexate (MTX) Versus Placebo Plus MTX in Participants With Moderate to Severe Active Rheumatoid Arthritis (RA)

Who this might be right for
Rheumatoid Arthritis
Aclaris Therapeutics, Inc. 251
Large-scale testing (Phase 3)Enrolling By InvitationNCT06726096
What this trial is testing

Phase III Trial of VDJ001 In Patients With Moderate-to-severe Active Rheumatoid Arthritis

Who this might be right for
Rheumatoid Arthritis (RA)Anti IL-6R
Beijing VDJBio Co., LTD. 615
Large-scale testing (Phase 3)Ended earlyNCT05246280
What this trial is testing

Tc 99m Tilmanocept Imaging for Early Prediction of Anti-TNFα Therapy Response in Moderate to Severe Active RA

Who this might be right for
Rheumatoid Arthritis
Navidea Biopharmaceuticals 169
Large-scale testing (Phase 3)Study completedNCT01951170
What this trial is testing

An Open-Label Study of RoActemra/Actemra (Tocilizumab) in Patients With Moderate to Severe Active Rheumatoid Arthritis

Who this might be right for
Rheumatoid Arthritis
Hoffmann-La Roche 52
Large-scale testing (Phase 3)Study completedNCT02638259
What this trial is testing

Comparative Efficacy and Safety Study of GP2015 and Enbrel® in Patients With Rheumatoid Arthritis

Who this might be right for
Rheumatoid Arthritis
Sandoz 376
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07748728
What this trial is testing

TLL-018 in Patients With Moderate to Severe Active Rheumatoid Arthritis With Inadequate Response or Intolerance to csDMARDs

Who this might be right for
Rheumatoid Arthritis (RA)
Hangzhou Highlightll Pharmaceutical Co., Ltd 90
Post-approval studies (Phase 4)Study completedNCT02187055
What this trial is testing

An Efficacy And Safety Study Evaluating Tofacitinib With And Without Methotrexate Compared To Adalimumab With Methotrexate

Who this might be right for
Rhematoid Arthritis
Pfizer 1,152
Testing effectiveness (Phase 2)Ended earlyNCT02862574
What this trial is testing

Andecaliximab as Add-On Therapy to a Tumor Necrosis Factor Inhibitor and Methotrexate Regimen in Adults With Moderately to Severely Active Rheumatoid Arthritis

Who this might be right for
Rheumatoid Arthritis
Gilead Sciences 15
Large-scale testing (Phase 3)Study completedNCT02675426
What this trial is testing

A Study Comparing Upadacitinib (ABT-494) to Placebo in Adults With Rheumatoid Arthritis on a Stable Dose of Conventional Synthetic Disease-Modifying Antirheumatic Drugs (csDMARDs) Who Have an Inadequate Response to csDMARDs Alone

Who this might be right for
Rheumatoid Arthritis
AbbVie 661
Large-scale testing (Phase 3)Study completedNCT02744755
What this trial is testing

Clinical Trial to Compare Treatment With GP2017 and Humira® in Patients With Rheumatoid Arthritis

Who this might be right for
Rheumatoid Arthritis
Sandoz 353
Testing effectiveness (Phase 2)WithdrawnNCT02795299
What this trial is testing

Study Evaluating Gerilimzumab´s Safety/Efficacy for Patients MTX or TNFα Antagonist Failed in Rheumatoid Arthritis

Who this might be right for
Rheumatoid Arthritis
Bird Rock Bio, Inc.
Large-scale testing (Phase 3)Ended earlyNCT01955733
What this trial is testing

Safety and Efficacy of BI 695500 in Patients With Moderately to Severely Active Rheumatoid Arthritis

Who this might be right for
Arthritis, Rheumatoid
Boehringer Ingelheim 91
Testing effectiveness (Phase 2)Study completedNCT01851707
What this trial is testing

Study Evaluating Duvelisib in Subjects With Moderate to Severe Rheumatoid Arthritis and an Inadequate Response to Methotrexate Alone

Who this might be right for
Rheumatoid Arthritis
SecuraBio 322
Next Page

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation